868594-48-3

Basic information

• Product Name: Nonaethylene glycol Monobenzyl ether
• Synonyms: BnO-PEG9-OH;Nonaethylene glycol Monobenzyl ether;1-Phenyl-2,5,8,11,14,17,20,23,26-nonaoxaoctacosan-28-ol;Benzyl-PEG10-alcohol
• CAS NO: 868594-48-3
• Molecular Formula: C₂₅H₄₄O₁₀
• Molecular Weight: 504.61086
• Mol File: 868594-48-3.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: Nonaethylene glycol Monobenzyl ether(CAS DataBase Reference)
• NIST Chemistry Reference: Nonaethylene glycol Monobenzyl ether(868594-48-3)
• EPA Substance Registry System: Nonaethylene glycol Monobenzyl ether(868594-48-3)

Safety Data

• Hazardous Substances Data: 868594-48-3(Hazardous Substances Data)

Usage

Uses

Used in Manufacturing Industry:
Nonaethylene glycol Monobenzyl ether is used as a solvent in the production of inks, coatings, and adhesives due to its ability to dissolve a wide range of substances, which enhances the manufacturing process and the quality of the final products.
Used in Anti-Icing and Deicing Products:
In the aviation and transportation sectors, Nonaethylene glycol Monobenzyl ether is utilized as a component in anti-icing and deicing formulations. Its solvent properties contribute to the effectiveness of these products in preventing and removing ice, ensuring safety and functionality.
Safety Note:
While Nonaethylene glycol Monobenzyl ether is a versatile chemical, it is crucial to handle it with care due to its potential toxicity if ingested or absorbed through the skin. Additionally, it can cause eye and respiratory irritation, emphasizing the need for proper safety measures during its use.

Upstream product

• 868594-47-2 1-(triphenylmethyloxy)-26-(phenylmethyloxy)-3,6,9,12,15,18,21,24-octaoxahexaeicosane 
• 3386-18-3 nonaethylene glycol 
• 100-44-7 benzyl chloride 
• 105891-52-9 [2-(2-{2-[2-(2-Chloro-ethoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxymethyl]-benzene 
• 125274-16-0 1,1,1-triphenyl-2,5,8,11-tetraoxatridecan-13-ol 
• 57671-28-0 2-(2-{2-[2-(2-benzyloxyethoxy)ethoxy]ethoxy}ethoxy)ethanol 
• 4792-15-8 Pentaethylene glycol 
• 669556-27-8 toluene-4-sulfonic acid 2-{2-[2-(2-{2-[2-(4-methoxy-benzyloxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-ethoxy}-ethyl ester 
• 669555-91-3 2-{2-[2-(2-{2-[2-(4-methoxy-benzyloxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-ethoxy}-ethanol 
• 112-27-6 2,2'-[1,2-ethanediylbis(oxy)]bisethanol 
• 669556-37-0 17-(tetrahydro-2H-pyran-2-yloxy)-3,6,9,12,15-pentaoxaheptadecyl 4-methylbenzenesulfonate 
• 60221-37-6 8-(1H-tetrahydropyran-2-yloxy)-3n₆³-dioxaoctan-1-ol 
• 69502-33-6 2-(2-(2-((tetrahydro-2H-pyran-2-yl)oxy)ethoxy)ethoxy)ethyl 4-methylbenzenesulfonate 
• 100-39-0 benzyl bromide 

Downstream Products

• 393517-91-4 toluene-4-sulfonic acid 2-[2-(2-{2-[2-(2-{2-[2-(2-benzyloxy-ethoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-ethyl ester 

Relevant articles and documents

A amphiphatic compound containing heterocyclic structure with nitrogen-atom ring, the preparation method and a surfactant composition containing the compound

The present invention relates to: a novel compound having amphiphilic properties, containing a nitrogen-atom ring; and a method for manufacturing the same. The novel compound of the present invention is very effective as an active component of a surfactant which can maintain a form of a sample for a long time in nucleic acid analysis or blood analysis.COPYRIGHT KIPO 2020

Synthesis of bifunctional integrin-binding peptides containing PEG spacers of defined length for non-viral gene delivery

Improving the buffer and serum stability of non-viral gene delivery vectors, and increasing their circulation time in vivo, is an important focus of current research in gene therapy. The most successful strategies to date have involved shielding the complexes with large polydisperse PEG adducts. However, this approach is accompanied by a fall in transfection efficiency. In this paper we describe the solid-phase synthesis of a series of bifunctional peptides bearing short PEG spacers of defined structure as components of lipopolyplex gene delivery vectors. Short, high-yielding routes to a series of PEG-amino acids are described: these PEG-amino acids can be used in varying combinations to afford bifunctional peptides with varying lengths of PEG spacers by using standard solid-phase synthesis techniques. A series of lipopolyplexes were formulated using these bifunctional peptides, and their transfection properties assessed. Dynamic light scattering measurements on the complex with the best transfection properties showed that in phosphate-buffered saline this complex was considerably more stable, and aggregated more slowly, than a complex formulated using a similar peptide lacking the short PEG spacer. Wiley-VCH Verlag GmbH & Co. KGaA, 2008.

Multigram Synthesis of Well-Defined Extended Bifunctional Polyethylene Glycol (PEG) Chains

A series of novel, well-defined, unsymmetrical poly(ethylene glycol) chains of the type X(OCH2-CH2)nY (where X = protecting group; Y = nucleofuge or a different protecting group; n = 3, 6, 9, 12, 15, 18, and 24) were prepared in high yields by applying orthogonal protecting groups. The purity of the compounds was fully verified by elemental and high-resolution mass spectrometry analyses.